Scleroderma Patients with Pulmonary Artery Hypertension: A Case Report

Muhammad Miftahussurur, Joewono Soeroso

2017

Abstract

Scleroderma or systemic sclerosis (SSc) is a multiorgan connective tissue disorder involving the skin, lungs, heart, digestive tract, musculoskeletal system, and peripheral circulation. Pulmonary arterial hypertension (PAH) is an increase in mean pulmonary artery pressure > 25 mmHg as measured by echocardiography or catheterization. The incidence of PAHs with SSc is so rare that reports, in this case, are necessary. Objective: to describe the management of PAH patients with SSc. Case: a 32-year-old patient experiencing PAHs with SSc has stiffness of the mouth and is difficult to open. The ECG shows a sinus tachycardia with a Right axis destination and a cardiomegaly thorax photo with a 64% cardio-thorax ratio. Some clinical data show autoimmunity. Treatment is oxygen, diuretic, thrombolytic, and immunosuppressive drugs. Conclusions: Reports of PAH treatment with SSC are essential for the improvement of therapy

Download


Paper Citation


in Harvard Style

Miftahussurur M. and Soeroso J. (2017). Scleroderma Patients with Pulmonary Artery Hypertension: A Case Report.In Proceedings of the International Meeting on Regenerative Medicine - Volume 1: IMRM, ISBN 978-989-758-334-6, pages 413-419. DOI: 10.5220/0007322404130419


in Bibtex Style

@conference{imrm17,
author={Muhammad Miftahussurur and Joewono Soeroso},
title={Scleroderma Patients with Pulmonary Artery Hypertension: A Case Report},
booktitle={Proceedings of the International Meeting on Regenerative Medicine - Volume 1: IMRM,},
year={2017},
pages={413-419},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0007322404130419},
isbn={978-989-758-334-6},
}


in EndNote Style

TY - CONF

JO - Proceedings of the International Meeting on Regenerative Medicine - Volume 1: IMRM,
TI - Scleroderma Patients with Pulmonary Artery Hypertension: A Case Report
SN - 978-989-758-334-6
AU - Miftahussurur M.
AU - Soeroso J.
PY - 2017
SP - 413
EP - 419
DO - 10.5220/0007322404130419